Skip to main content
SpringerLink
Log in

Das Verhalten des Plasmacorticosteroidspiegels unter der Einwirkung einer Oestrogen-Androgenkombination

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

1. Unter Zusatz von Androgenen zu Oestrogenen gelingt es, die durch letztere bedingte Steigerung der Plasma-CS zu blockieren.

2. Die dazu erforderliche Dosisrelation von Oestrogen zu Androgen beträgt 1:15.

3. Unter dieser Dosis war ein sicherer Effekt des Androgenzusatzes zu den Oestrogengaben auf den Plasma-CS-Spiegel nicht nachzuweisen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Venning, E. H.: Adrenal function in pregnancy. Endocrinology39, 203 (1946).

    Google Scholar 

  2. Gemzell, C. A.: Variations in plasma levels of 17-hydroxycorticostcroids in mother and infant following parturition. Acta endocr.17, 100 (1954).

    Google Scholar 

  3. Doe, R. P., H. H. Zinneman, E. B. Flink andR. A. Ulstrom: Significance of concentration of nonprotein-bound plasma cortisol in normal subjects, Cushing's Syndrome, pregnancy and during estrogen therapy. J. clin. Endocr.20, 1484 (1960).

    Google Scholar 

  4. Taliaferro, J., F. Cobey andL. Leone: Effect of diethylstilbestrol on plasma 17-hydroxycorticosteroid levels in humans. Proc. Soc. exp. Biol. (N.Y.)92, 742 (1956).

    Google Scholar 

  5. Wallace, E. Z., H. J. Silverberg andA. C. Carter: Effect of ethinyl-estradiol on plasma 17-hydroxycorticosteroids, ACTH-responsiveness and hydrocortisone in man. Proc. Soc. exp. Biol. (N.Y.)95, 805 (1957).

    Google Scholar 

  6. Robertson, M. E., M. Stiefel andJ. C. Laidlaw: The influence of estrogen on the secretion, disposition and biologic activity of cortisol. J. clin. Endocr.19, 1381 (1959).

    Google Scholar 

  7. Peterson, R. E., G. Nokes, P. S. Chen andR. L. Black: Estrogens and adrenocortical function in man. J. clin. Endocr.20, 495 (1960).

    Google Scholar 

  8. Herrmann, W. L., I. K. Schindl andP. K. Bondy: Effect of estrogen on steroid levels in plasma and urine. Proc. Soc. exp. Biol. (N.Y.)103, 103 (1960).

    Google Scholar 

  9. Schwarz, K., u.H. Schmidt-Elmendorff: Der Einfluß von Oestradiol auf die freien Plasma-17-Hydroxycorticosteroide in der Menopause und beim Turner-Syndrom. Klin. Wschr.38, 139 (1960).

    Google Scholar 

  10. Schwarz, K., u.K. Kopetz: Die Wirkung von Oestron und Oestriol auf die freien 17-Hydroxycorticosteroide im Blutplasma. Klin. Wschr.38, 335 (1960).

    Google Scholar 

  11. Marks, L. J., G. R. Friedman andF. J. Duncan: Effect of estrogen administration on hydrocortisone metabolism in man. J. Lab. clin. Med.57, 47 (1961).

    Google Scholar 

  12. Slaunwhite jr., W. R., andA. A. Sandberg: Transcortin: A corticosteroid-binding protein of plasma. J. clin. Invest.38, 384 (1959).

    Google Scholar 

  13. Sandberg, A. A., andW. R. Slaunwhite jr.: Transcortin: A corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J. clin. Invest.38, 1290 (1959).

    Google Scholar 

  14. Schwarz, K., u.K. Kopetz: Der Einfluß einzelner Oestrogene auf den Gehalt der freien 17-, 21-Hydroxy-20-keto-Corticosteroide im Plasma. 7. Symposion der Dtsch. Ges. für Endokrinologie, Homburg/Saar 1960, S. 263.

  15. Gemzell, C. A., andG. Notter: Effect of androgens on plasma levels of 17-hydroxycorticosteroids. J. clin. Endocr.16, 483 (1956).

    Google Scholar 

  16. Brown, H., andC. Migeon: Effect of intravenous administration of testosteron and progesteron on the plasma 17-hydroxycorticosteroid level in man. J. clin. Endocr.16, 227 (1956).

    Google Scholar 

  17. Eik-Nes, K., D. H. Nelson andL. T. Samuels: Determination of 17,21-hydroxycorticosteroids in plasma. J. clin. Endocr.13, 1280 (1953).

    Google Scholar 

  18. Troop, R. C.: Influence of gonadal hormones on the metabolism of cortisone. Endocrinology64, 671 (1959).

    Google Scholar 

  19. Hagen, A. A., andR. C. Troop: Influence of age, sex and adrenocortical status on hepatic reduction of cortisone in vitro. Endocrinology67, 194 (1960).

    Google Scholar 

  20. Yates, F. E., A. L. Herbst andJ. Urquhart: Sex difference in rate of ring-A-reduction of Δ-4-3-ketosteroids in vitro by rat liver. Endocrinology63, 887 (1958).

    Google Scholar 

  21. Forchielli, E., K. Brown-Grant andR. J. Dorfman: Steroid Δ-4-hydrogenases of rat liver. Proc. Soc. exp. Biol. (N.Y.)99, 594 (1958).

    Google Scholar 

  22. Kitay, J. I.: Sex differences in adrenal cortical secretion in the rat. Endocrinology68, 818 (1961).

    Google Scholar 

  23. Rubin, B. L., andH. J. Strecker: Further studies on the sex difference in 3-β-hydroxysteroid dehydrogenase activity of rat livers. Endocrinology69, 257 (1961).

    Google Scholar 

  24. Smith, L. L., R. W. Steenburg, U. F. Gruber, A. J. Kaalstad andF. D. Moore: The effect of testosterone on corticosteroids in surgical trauma: Studies in man. J. clin. Endocr.20, 919 (1960).

    Google Scholar 

  25. Geist, S. H., andU. I. Salmon: Androgen therapy in gynecology. J. Amer. med. Ass.117, 2207 (1941).

    Google Scholar 

  26. Margolese, M. S.: Control of induced estrogen bleeding. J. clin. Endocr.4, 394 (1944).

    Google Scholar 

  27. Benjamin, H.: Endocrine gerontotherapy; use of sex hormone combinations in female. J. Geront.4, 222 (1949).

    Google Scholar 

  28. Glass, S. J.: Advantages of combined estrogen-androgen therapy. J. clin. Endocr.10, 1616 (1950).

    Google Scholar 

  29. Greenblatt, R. B., W. E. Barfield, J. F. Garner, G. L. Calk andJ. P. Harrod: Evaluation of estrogen, androgen, estrogen-androgen combination, and placebo in treatment of menopause. J. clin. Endocr.10, 1547 (1950).

    Google Scholar 

  30. Katzman, B.: Use of androgen-estrogen combination to prevent pain and lactation in puerperium. Amer. J. Obstet. Gynec.63, 1338 (1952).

    Google Scholar 

  31. Greenblatt, R. B., andW. E. Barfield: Hormonal control of functional uterine bleeding. Amer. J. Obstet. Gynec.63, 153 (1952).

    Google Scholar 

  32. Suenderhauf, H., u.H. Aeppli: Behandlung klimakterischer Ausfallserscheinungen mit einer Kombination von Ovocyclin und Perandren. Schweiz. med. Wschr.82, 589 (1952).

    Google Scholar 

  33. Boschnan, H. W., u.K. A. Geese: Über die Wirksamkeit injizierbarer oestrogener und androgener Depothormone und ihrer Mischungen beim klimakterischen Syndrom. Ärztl. Wschr.9, 833 (1954).

    Google Scholar 

  34. Edgren, R. A.: Estrogen antagonisms: Further remarks on temporal aspects of steroid block of estrogen-induced vaginal smear changes in mice. Endocrinology68, 639 (1961).

    Google Scholar 

  35. Edgren, R. A., andD. W. Calhoun: Estrogen antagonisms: The effects of various steroids on the uterine growth produced in mice by estriol. Experientia (Basel)16, 188 (1960).

    Google Scholar 

  36. Engstrom, W. W., andB. Markhardt: Influence of estrogen on thyroid function. J. clin. Endocr.14, 215 (1954).

    Google Scholar 

  37. Engstrom, W. W., B. Markhardt andE. Liebman: Effects of estrogens on serum precipitable iodine. Proc. Soc. exp. Biol. (N.Y.)81, 582 (1952).

    Google Scholar 

  38. Dowling, J. T., N. Freinkel andS. H. Ingbar: Effect of diethylstilbestrol on the binding of thyroxine in serum. J. clin. Endocr.16, 1491 (1956).

    Google Scholar 

  39. Federman, D. D., J. Robbins andJ. E. Rall: Effects of methyltestosterone on thyroid function, thyroxine metabolism and thyroid binding protein. J. clin. Invest.37, 1024 (1958).

    Google Scholar 

  40. Rosenberg, I. N., C. S. Ahn andM. L. Mitchell: Effects of anabolic steroids upon circulating thyroid hormones. J. clin. Endocr.22, 612 (1962).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aus der II. Medizinischen Klinik der Universität München, Germany

    K. Kopetz, K. Schwarz & K. P. Eymer

Authors
  1. K. Kopetz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. P. Eymer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Mit Unterstützung der Deutschen Forschungsgemeinschaft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kopetz, K., Schwarz, K. & Eymer, K.P. Das Verhalten des Plasmacorticosteroidspiegels unter der Einwirkung einer Oestrogen-Androgenkombination. Klin Wochenschr 40, 1181–1183 (1962). https://doi.org/10.1007/BF01494322

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01494322

Search

Navigation